{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T05:20:13Z","timestamp":1778736013357,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1R01CA245139"],"award-info":[{"award-number":["1R01CA245139"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s00259-022-05878-7","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T04:02:39Z","timestamp":1657252959000},"page":"3989-3999","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Predicting response of micrometastases with MIRDcell V3: proof of principle with 225Ac-DOTA encapsulating liposomes that produce different activity distributions in tumor spheroids"],"prefix":"10.1007","volume":"49","author":[{"given":"Sumudu","family":"Katugampola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianchao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aprameya","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stavroula","family":"Sofou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7057-8110","authenticated-orcid":false,"given":"Roger W.","family":"Howell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,8]]},"reference":[{"key":"5878_CR1","first-page":"531","volume":"35","author":"RW Howell","year":"1994","unstructured":"Howell RW. The MIRD schema: from organ to cellular dimensions. J Nucl Med. 1994;35:531\u20133.","journal-title":"J Nucl Med"},{"key":"5878_CR2","volume-title":"MIRD primer for absorbed dose calculations","author":"R Loevinger","year":"1991","unstructured":"Loevinger R, Budinger TF, Watson EE. MIRD primer for absorbed dose calculations. Revised. New York: The Society of Nuclear Medicine; 1991.","edition":"Revised"},{"key":"5878_CR3","first-page":"3S","volume":"40","author":"RW Howell","year":"1999","unstructured":"Howell RW, Wessels BW, Loevinger R, Watson EE, Bolch WE, Brill AB, et al. The MIRD perspective 1999. J Nucl Med. 1999;40:3S-10S.","journal-title":"J Nucl Med"},{"key":"5878_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-021-05406-z","author":"A Prasad","year":"2021","unstructured":"Prasad A, Nair R, Bhatavdekar O, Howe A, Salerno D, Sempkowski M, et al. Transport-driven engineering of liposomes for delivery of alpha-particle radiotherapy to solid tumors: effect on inhibition of tumor progression and onset delay of spontaneous metastases. Eur J Nucl Med Mol Imaging. 2021. https:\/\/doi.org\/10.1007\/s00259-021-05406-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5878_CR5","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1021\/acs.molpharmaceut.6b00439","volume":"13","author":"S Stras","year":"2016","unstructured":"Stras S, Holleran T, Howe A, Sofou S. Interstitial release of cisplatin from triggerable liposomes enhances efficacy against triple negative breast cancer solid tumor analogues. Mol Pharm. 2016;13:3224\u201333. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.6b00439.","journal-title":"Mol Pharm"},{"key":"5878_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.biomaterials.2017.03.035","volume":"130","author":"C Zhu","year":"2017","unstructured":"Zhu C, Sempkowski M, Holleran T, Linz T, Bertalan T, Josefsson A, et al. Alpha-particle radiotherapy: for large solid tumors diffusion trumps targeting. Biomaterials. 2017;130:67\u201375. https:\/\/doi.org\/10.1016\/j.biomaterials.2017.03.035.","journal-title":"Biomaterials"},{"key":"5878_CR7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2147\/IJN.S2736","volume":"3","author":"S Sofou","year":"2008","unstructured":"Sofou S. Radionuclide carriers for targeting of cancer. Int J Nanomed. 2008;3:181\u201399.","journal-title":"Int J Nanomed"},{"key":"5878_CR8","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3109\/09553002.2011.602379","volume":"88","author":"RW Howell","year":"2012","unstructured":"Howell RW, Rajon D, Bolch WE. Monte Carlo simulation of irradiation and killing in three-dimensional cell populations with lognormal cellular uptake of radioactivity. Int J Radiat Biol. 2012;88:115\u201322. https:\/\/doi.org\/10.3109\/09553002.2011.602379.","journal-title":"Int J Radiat Biol"},{"key":"5878_CR9","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1667\/RR0902.1","volume":"168","author":"PVSV Neti","year":"2007","unstructured":"Neti PVSV, Howell RW. Biological response to nonuniform distributions of 210Po in multicellular clusters. Radiat Res. 2007;168:332\u201340.","journal-title":"Radiat Res"},{"key":"5878_CR10","unstructured":"Neti PV, Howell RW. Log normal distribution of cellular uptake of radioactivity: implications for biologic responses to radiopharmaceuticals. J Nucl Med. 2006;47:1049\u201358. 47\/6\/1049 [pii]."},{"key":"5878_CR11","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.2967\/jnumed.107.048843","volume":"49","author":"PV Neti","year":"2008","unstructured":"Neti PV, Howell RW. Lognormal distribution of cellular uptake of radioactivity: statistical analysis of alpha-particle track autoradiography. J Nucl Med. 2008;49:1009\u201316. https:\/\/doi.org\/10.2967\/jnumed.107.048843.","journal-title":"J Nucl Med"},{"key":"5878_CR12","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nrc1893","volume":"6","author":"AI Minchinton","year":"2006","unstructured":"Minchinton AI, Tannock IF. Drug penetration in solid tumours. Nat Rev Cancer. 2006;6:583\u201392. https:\/\/doi.org\/10.1038\/nrc1893.","journal-title":"Nat Rev Cancer"},{"key":"5878_CR13","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.2967\/jnumed.113.131037","volume":"55","author":"B Vaziri","year":"2014","unstructured":"Vaziri B, Wu H, Dhawan AP, Du P, Howell RW. MIRD Pamphlet No. 25: MIRDcell V2.0 software tool for dosimetric analysis of biologic response of multicellular populations. J Nucl Med. 2014;55:1557\u201364. https:\/\/doi.org\/10.2967\/jnumed.113.131037.","journal-title":"J Nucl Med"},{"key":"5878_CR14","unstructured":"Howell RW, Wang J, Katugampola S. MIRDcell User Manual V3.11.01. 2022. https:\/\/mirdcell.njms.rutgers.edu\/publications.php."},{"key":"5878_CR15","doi-asserted-by":"publisher","unstructured":"Katugampola S, Wang J, Howell RW. MIRD Pamphlet No. 27: MIRDcell V3, a revised software tool for multicellular dosimetry and bioeffect modeling.\u00a0J Nucl Med. 2022. https:\/\/doi.org\/10.2967\/jnumed.121.263253.","DOI":"10.2967\/jnumed.121.263253"},{"key":"5878_CR16","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1021\/bc700440a","volume":"19","author":"MY Chang","year":"2008","unstructured":"Chang MY, Seideman J, Sofou S. Enhanced loading efficiency and retention of 225Ac in rigid liposomes for potential targeted therapy of micrometastases. Bioconjug Chem. 2008;19:1274\u201382. https:\/\/doi.org\/10.1021\/bc700440a.","journal-title":"Bioconjug Chem"},{"key":"5878_CR17","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1021\/acs.molpharmaceut.9b00812","volume":"17","author":"S Stras","year":"2020","unstructured":"Stras S, Howe A, Prasad A, Salerno D, Bhatavdekar O, Sofou S. Growth of metastatic triple-negative breast cancer is inhibited by deep tumor-penetrating and slow tumor-clearing chemotherapy: the case of tumor-adhering liposomes with interstitial drug release. Mol Pharm. 2020;17:118\u201331. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.9b00812.","journal-title":"Mol Pharm"},{"key":"5878_CR18","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.3109\/09553002.2012.683511","volume":"88","author":"JM Akudugu","year":"2012","unstructured":"Akudugu JM, Azzam EI, Howell RW. Induction of lethal bystander effects in human breast cancer cell cultures by DNA-incorporated iodine-125 depends on phenotype. Int J Radiat Biol. 2012;88:1028\u201338. https:\/\/doi.org\/10.3109\/09553002.2012.683511.","journal-title":"Int J Radiat Biol"},{"key":"5878_CR19","first-page":"1050","volume":"45","author":"PV Neti","year":"2004","unstructured":"Neti PV, Howell RW. Isolating effects of microscopic nonuniform distributions of 131I on labeled and unlabeled cells. J Nucl Med. 2004;45:1050\u20138.","journal-title":"J Nucl Med"},{"key":"5878_CR20","first-page":"521","volume":"35","author":"SM Goddu","year":"1994","unstructured":"Goddu SM, Rao DV, Howell RW. Multicellular dosimetry for micrometastases: dependence of self-dose versus cross-dose to cell nuclei on type and energy of radiation and subcellular distribution of radionuclides. J Nucl Med. 1994;35:521\u201330.","journal-title":"J Nucl Med"},{"key":"5878_CR21","first-page":"1902","volume":"36","author":"JA O'Donoghue","year":"1995","unstructured":"O\u2019Donoghue JA, Bardies M, Wheldon TE. Relationships between tumor size and curability for uniformly targeted therapy with beta-emitting radionuclides. J Nucl Med. 1995;36:1902\u20139.","journal-title":"J Nucl Med"},{"key":"5878_CR22","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1118\/1.596404","volume":"16","author":"RW Howell","year":"1989","unstructured":"Howell RW, Rao DV, Sastry KSR. Macroscopic dosimetry for radioimmunotherapy: nonuniform activity distributions in solid tumors. Med Phys. 1989;16:66\u201374.","journal-title":"Med Phys"},{"key":"5878_CR23","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1667\/RR14766.1","volume":"188","author":"JH Solanki","year":"2017","unstructured":"Solanki JH, Tritt T, Pasternack JB, Kim JJ, Leung CN, Domogauer JD, et al. Cellular response to exponentially Increasing and decreasing dose rates: Implications for treatment planning in targeted radionuclide therapy. Radiat Res. 2017;188:221\u201334. https:\/\/doi.org\/10.1667\/RR14766.1.","journal-title":"Radiat Res"},{"key":"5878_CR24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2967\/jnumed.119.227835","volume":"61","author":"CN Leung","year":"2020","unstructured":"Leung CN, Canter BS, Rajon D, Back TA, Fritton JC, Azzam EI, et al. Dose-dependent growth delay of breast cancer xenografts in the bone marrow of mice treated with radium-223: the role of bystander effects and their potential for therapy. J Nucl Med. 2020;61:89\u201395. https:\/\/doi.org\/10.2967\/jnumed.119.227835.","journal-title":"J Nucl Med"},{"key":"5878_CR25","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1158\/1541-7786.MCR-21-0005","volume":"19","author":"BS Canter","year":"2021","unstructured":"Canter BS, Leung CN, Fritton JC, Back T, Rajon D, Azzam EI, et al. Radium-223-induced bystander effects cause DNA damage and apoptosis in disseminated tumor cells in bone marrow. Mol Cancer Res. 2021;19:1739\u201350. https:\/\/doi.org\/10.1158\/1541-7786.MCR-21-0005.","journal-title":"Mol Cancer Res"},{"key":"5878_CR26","first-page":"277","volume":"33","author":"RW Howell","year":"1992","unstructured":"Howell RW, Narra VR, Rao DV. Absorbed dose calculations for rapidly growing tumors. J Nucl Med. 1992;33:277\u201381.","journal-title":"J Nucl Med"},{"key":"5878_CR27","first-page":"1923","volume":"36","author":"SM Goddu","year":"1995","unstructured":"Goddu SM, Howell RW, Rao DV. A generalized approach to absorbed dose calculations for dynamic tumor and organ masses. J Nucl Med. 1995;36:1923\u20137.","journal-title":"J Nucl Med"},{"key":"5878_CR28","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1089\/108497803322285215","volume":"18","author":"A Malaroda","year":"2003","unstructured":"Malaroda A, Flux GD, Buffa FM, Ott RJ. Multicellular dosimetry in voxel geometry for targeted radionuclide therapy. Cancer Biother Radiopharm. 2003;18:451\u201361.","journal-title":"Cancer Biother Radiopharm"},{"key":"5878_CR29","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1080\/09553002.2021.1951392","volume":"97","author":"DA Rajon","year":"2021","unstructured":"Rajon DA, Canter BS, Leung CN, Back TA, Fritton JC, Azzam EI, et al. Modeling bystander effects that cause growth delay of breast cancer xenografts in bone marrow of mice treated with radium-223. Int J Radiat Biol. 2021;97:1217\u201328. https:\/\/doi.org\/10.1080\/09553002.2021.1951392.","journal-title":"Int J Radiat Biol"},{"key":"5878_CR30","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1080\/09553000050176315","volume":"76","author":"DE Charlton","year":"2000","unstructured":"Charlton DE. Radiation effects in spheroids of cells exposed to alpha emitters. Int J Radiat Biol. 2000;76:1555\u201364.","journal-title":"Int J Radiat Biol"},{"key":"5878_CR31","doi-asserted-by":"publisher","unstructured":"Roeske JC, Stinchcomb TG. The average number of alpha-particle hits to the cell nucleus required to eradicate a tumour cell population.\u00a0Phys Med Biol. 2006;51:N179\u201386. https:\/\/doi.org\/10.1088\/0031-9155\/51\/9\/N02.","DOI":"10.1088\/0031-9155\/51\/9\/N02"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-022-05878-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-022-05878-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-022-05878-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T17:10:06Z","timestamp":1664557806000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-022-05878-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,8]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["5878"],"URL":"https:\/\/doi.org\/10.1007\/s00259-022-05878-7","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,8]]},"assertion":[{"value":"10 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Sumudu Katugampola (SK), Jianchao Wang (JW), and Roger W. Howell (RWH) declare they have financial interests. RWH holds patent US 9,623,262 patent for MIRDcell V2. SK, JW, and RWH have petitioned Rutgers University to apply for a patent for MIRDcell V3.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}